Compare Canopy Growth Corp (CGC) vs HSBC Holdings plc (HSBC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Canopy Growth Corp vs HSBC Holdings plc — how do they compare? Canopy Growth Corp trades at $1.01 (market cap $421.10M), while HSBC Holdings plc trades at $104.08 (market cap $353.82B). The key difference: HSBC Holdings plc is far larger — about 840.2× Canopy Growth Corp's market cap, and HSBC Holdings plc pays a 3.63% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | HSBC | |
|---|---|---|
Market Cap | $421.10M | $353.82B |
Sector | Health | Technology |
52-Week High | $1.92 | $107.86 |
52-Week Low | $0.86 | $63.84 |
Enterprise Value | $378.55M | — |
Dividend Yield | — | 3.63% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CGC trades at $0.95, down 1.86% in the last session, with a neutral technical signal and mixed analyst ratings (9 buy, 11 hold, 7 sell). The company reported Q1 2027 revenue growth of 13% year-over-year, beating estimates, but continues to post net losses. Recent news highlights expansion in European cannabis markets and cost-cutting efforts, while the stock remains volatile amid regulatory uncertainty.
Outlook is cautious due to persistent losses and high debt, though improving cash flow and revenue growth offer potential upside. Key risks include regulatory delays in U.S. cannabis rescheduling and competitive pressures. Investors should weigh the speculative nature against any positive regulatory catalysts.
HSBC's stock trades at $103.88, up 0.54% today, with a bullish technical signal from moving averages and support near $103. Recent Q2 2026 earnings beat expectations with a 7% revenue rise to $19 billion (Defense World, 2026-08-06), and the company announced a $1 billion buyback (WSJ, 2026-08-04). Valuation metrics include a P/E of 14.74 and ROE of 12.44%, reflecting solid profitability.
The outlook is positive due to strong earnings momentum and shareholder returns, but risks include a recent analyst downgrade (Citi to 'neutral' on August 5, 2026) and exposure to Asian market volatility. With 38.1% of analysts rating it a buy, the stock offers growth potential tempered by competitive and regulatory headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Canopy Growth Corp
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →About HSBC Holdings plc
HSBC is one of the world's largest banking and financial services organizations. It serves customers worldwide through four global businesses: Retail, Commercial, Global Banking, and Private Banking.
Read more on HSBC →
